Biopharma is reshaping the healthcare industry, and smart investors are paying close attention. The healthcare sector could see major changes as artificial intelligence accelerates drug discovery, ...

New Report from BCG Explores Challenges and Strategic Shifts Ahead for 2026 That Could Further Erode Pharma's Longstanding Social Contract BOSTON, Jan. 8, 2026 /PRNewswire/ -- Biopharma enters 2026 ...

Emerging biopharma is a segment of companies are responsible for a great deal of innovation, research and development within the life sciences sector. In fact, emerging biopharma has gradually taken ...

This article was written by the Bloomberg Indices product team. Amidst the strong revenue gains in the fourth quarter of 2023, Eli Lilly has ascended to the eighth position in the Bloomberg US Large ...